![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0115.jpg)
/
Patient presentation
•
65 year old female
•
Performance status 90%
•
Comorbidities:
•
No relevant until
diagnosis of cancer
•
Paraneoplastic syndroms:
•
Anemia
•
Depression after diagnosis
of cancer
07.09.17
ESTRO SBRT COURSE 2017 - Matthias Guckenberger
3
/
Initial staging & histopathology
Ø
NSCLC cT2 cN1 cM1 (adrenal), Adeno Carcinoma
Ø
Synchronous oligo-metastatic stage IV NSCLC
Ø
EGFR, BRAF, KRAS, ERBB2, ALK, ROS1 negative
08/2015
Primary
Hilar LN
Adrenal
07.09.17
ESTRO SBRT COURSE 2017 - Matthias Guckenberger
4